01. A Pilot Study on the Safety and Adequacy of a Novel Ecofriendly Hemodialysis Prescription–Green Nephrology. Kidney Int Rep (2024).
02. Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP): Rationale and Design of a Pragmatic, Registry-Based, Cluster Randomized Controlled Trial. Can J Kidney Health Dis. 2020; 7: 2054358119887988. doi.
03. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.
04. In-Center Hemodialysis Six Times per Week versus Three Times per Week The FHN Trial Group*. N Engl J Med 2010;363:2287-300.
05. Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure. N Engl J Med 2023;389:700-9.
06. Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double‑blinded, randomized controlled trial (the MAINTAIN IRON trial). Nature Portfolio.
07. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis. N Engl J Med 2019;380:447-58.
08. Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D). Am J Nephrol. 2022 Jun; 53(5): 343–351.
09. EFFECT OF DIALYSIS DOSE AND MEMBRANE FLUX IN MAINTENANCE HEMODIALYSIS. N Engl J Med, Vol. 347, No. 25 · December 19, 2002.
10. Effect of the Hemodialysis Prescription on Patient Morbidity — Report from the National Cooperative Dialysis Study. N Engl J Med 1981;305:1176-1181. DOI:.
11. Effect of Membrane Permeability on Survival of Hemodialysis Patients. J Am Soc Nephrol 20: 645–654, 2009.
12. A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis. N engl j med 363;7.
13. Effect of Online Hemodiafiltration on All-Cause Mortality and Cardiovascular Outcomes. J Am Soc Nephrol. 2012 Jun; 23(6): 1087–1096.
14. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study.
15. High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients. J Am Soc Nephrol. 2013 Feb 28; 24(3): 487–497. doi.
16. Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney International Volume 91, Issue 6, June 2017, Pages 1495-1509.
17. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study. Kidney International, Vol. 57, Suppl. 74 (2000), pp. S-74–S-81.
18. The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, Data Elements, and Methodology. American Journal of Kidney Diseases, Vol 44, No 5, Suppl 2 (November), 2004: pp S7-S15.
19. Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease. American Heart Journal.
20. Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease. N Engl J Med 2006;355:2085-2098 DOI.
21. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.
